– Shock Absorber for the Knee Targets Patients Who Are Seeking Alternatives to Joint Replacement HAYWARD, Calif. – Moximed®, Inc. announced today that the first patient has been treated in an FDA-approved IDE study for its latest generation unicompartmental unloading implant, the Atlas…
– Stepping Stones Home & Care opent 11e zorgvilla voor zorgbehoevende ouderen De prachtige stadsvilla aan de Hogelandsingel 21 in Enschede krijgt een nieuwe bestemming. Stepping Stones Home & Care realiseert hier als nieuwe huurder een kleinschalige woonzorgvoorziening met 24 appartementen…
– Topline data to be presented today at NACFC LEIDEN, the Netherlands (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that clinical study PQ-010-002, a proof-of-concept study of nasal potential difference (NPD), demonstrated that QR-010 restored CFTR function…
– San Diego, USA and Palma, Spain - Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced successful initiation of the first clinical trial of its lead candidate, SNF472, for the treatment of the orphan…
– Funding will be used to support go-to-market activities in Europe BARCELONA – Medical diagnostics company STAT-Diagnostica has closed an extension of its Series C financing with Siemens Venture Capital. The additional proceeds will be used to support the 2017 European launch of its…
– Acacia Pharma announces positive results from a pivotal Phase 3 trial of BAREMSIS™ for the treatment of post-operative nausea and vomiting BAREMSIS now shown to treat PONV, as well as prevent it Cambridge, UK – Acacia Pharma Group plc ("Acacia Pharma"), the supportive care company…
– Equity Offering to Support Heart Failure Trial and European Commercial Expansion Minneapolis – CVRx, Inc., a private medical device company, has announced an equity financing totaling $93 million. Gilde Healthcare participated in the financing alongside existing investors, Johnson…
– Board will be strengthened with industry experts and Enrique Vega appointed as new CEO Mont-Saint-Guibert, Belgium – Nyxoah S.A., a medical device company focused on developing a neurostimulation based, disruptive therapy for patients suffering from Obstructive Sleep Apnea (OSA),…
– NightBalance raises EUR 12.5 million to support the commercial roll-out of the Sleep Position Trainer in Europe and the U.S. Supervisory Board and Management team strengthened with industry experts Delft, the Netherlands – NightBalance BV, a leading innovator of obstructive sleep…
– Former Head of R&D at Orexigen Therapeutics and Therapeutic Area Head for Nephrology at Amgen appointed as CMO CMO appointment and launch of US subsidiary are significant steps in establishing a US presence Palma de Mallorca, Spain - Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical…
– Results from Multi-center, Prospective Study with Unicompartmental Joint Unloading Device for the Knee Presented at ESSKA / Moximed Commercializing Atlas System in Europe
– Agendia, Inc. announced that using the company's MammaPrint® assay, patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological criteria can avoid chemotherapy.
– Medical diagnostics company STAT-Diagnostica has closed a Series C financing round totaling EUR 25 million. The proceeds will be used to prepare for the 2017 European launch of its DiagCORE Near Patient Testing system.
– Acacia Pharma Group announces the initiation of its second pivotal Phase 3 treatment study, investigating BAREMSIS™ in surgical patients who develop post-operative nausea & vomiting, despite having received antiemetic prophylaxis before surgery.
– Ede - NIZO food research, een internationale contract research organisatie (CRO) voor bedrijven actief in voeding en gezondheidsmarkten, kondigt vandaag aan dat Gilde Healthcare is toegetreden als aandeelhouder om lange termijn groei verder te faciliteren. Jasper van Gorp, Managing…
– SAN DIEGO, Calif. – ResMed (NYSE:RMD), a leading innovator in sleep-disordered breathing and respiratory care, today announced it has entered into a definitive agreement to acquire Inova Labs Inc., a privately-held medical device company specializing in the development and commercialization…
– Cambridge, UK – Acacia Pharma Group plc, the supportive care company developing products for US and international markets, announces positive results from a Phase 3 study investigating BAREMSIS™ (amisulpride injection, formerly APD421) in combination with standard antiemetics for…
– Partnership aims to advance development of novel immune checkpoint therapies as Baxalta expands oncology leadership in orphan diseases Symphogen to receive $175 million (€160 million) upfront, in addition to potential future milestone payments and royalties BANNOCKBURN, Ill. and…